| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V40665 | 1V209 | 1062444-54-5 | 1V209 is a novel and potent Toll-like receptor 7 (TLR7) agonistwithanti-tumor activity. |
|
V125364 | 3D-Monophosphoryl Lipid (12,16) free acid | 220048-49-7 | 3D-Monophosphoryl Lipid (12,16) free acid is a TLR4 agonist that can be used as a vaccine adjuvant to enhance the immunogenicity of vaccines. |
|
V128024 | ABB071 | ABB071 is a humanized anti-CD180 monoclonal antibody. | |
|
V128032 | ABC-015 | ABC-015 is a human monoclonal antibody (mAb) that targets KLRG1. | |
|
V74342 | ABR-238901 | 1638200-22-2 | ABR-238901 is an orally bioactive S100A8/A9 blocker that can inhibit the interaction of S100A8/A9 with its receptors RAGE (receptor for advanced glycation end products) and TLR4 (toll-like receptor 4). |
|
V74373 | Agatolimod sodium (ODN 7909; PF-3512676; CpG 7909) | 541547-35-7 | Agatolimod sodium (ODN 7909) is a class B CpG ODN and a< B >TLR9 agonist. |
|
V51784 | AXC-715 hydrochloride | 2490497-93-1 | AXC-715 (T785) HCl is a TLR7/TLR8 dual agonist obtained from patent WO2020168017 A1. |
|
V103689 | AYK005 | 3031612-93-5 | AYK005 is a TLR7/8 type vaccine adjuvant. |
|
V78440 | Biotin-labeled ODN 1585 sodium | Biotin-labeled ODN 1585 (sodium) is a potent inducer of IFN and TNFα production. | |
|
V132006 | Cobitolimod sodium scrambled negative control | The Cobitolimod sodium scrambled negative control is a negative control with the sequence of Cobitolimod sodium scrambled. | |
|
V87020 | CpG ODN 10101 sodium | CpG ODN 10101 sodium is a synthetic oligodeoxynucleotide (ODN) that is a Toll-like receptor 9 (TLR9) agonist. | |
|
V132466 | Creatine ethyl ester | 15366-29-7 | Creatine ethyl ester is a commonly used and readily available form of creatine in supplements. |
|
V3815 | CU-CPT-8m | 125079-83-6 | CU-CPT-8m is a novel, potent and specific antagonist ofToll-like receptor 8 (TLR8)with immunomodulatory effects. |
|
V3816 | CU-CPT-9a | 2165340-32-7 | CU-CPT-9a, an analog ofCU-CPT-8m, is a potent and specificantagonist/inhibitor of TLR8 (Toll-like receptor 8) (IC50 = 0.5 nM) with the potential to be used for treating autoimmune diseases. |
|
V3817 | CU-CPT-9b | 2162962-69-6 | CU-CPT-9b, an analog ofCU-CPT-8m and CU-CPT-9a, is a specificantagonist of TLR8 (Toll-like receptor 8) with IC50 of 0.7 nM. |
|
V3818 | CU-CPT17e | 2109805-75-4 | CU-CPT17e is a multi-TLR (Toll-like receptor) agonist that activates TLR3, TLR8, and TLR9 with immunomodulatory activities. |
|
V20340 | E6446 HCl | 1345675-25-3 | E6446 is a synthetic antagonist of nucleic acid-sensing TLRs. |
|
V79421 | FITC-labeled Agatolimod sodium | FITC-labeled Agatolimod (sodium) is a class B CpG ODN and a TLR9 agonist. | |
|
V77015 | FITC-labeled ODN 1018 sodium | FITC-labeled ODN 1018 (sodium) is a TLR9 agonist. | |
|
V79424 | FITC-labeled ODN 1826 sodium | FITC-labeled ODN 1826 (sodium) is a class B CpG ODN and a TLR9 agonist. |